
Benjamin Powers
Associate Professor, Medical Oncology · University of Kansas School of Medicine
Credentials: · · · · ·
History
Research
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
New England Journal of Medicine · 2023 · 739 citations
Journal for ImmunoTherapy of Cancer · 2021 · 144 citations
The Lancet · 2024 · 75 citations
- ES
5 papers
- CB
4 papers
- CR
4 papers

4 papers

4 papers

4 papers

2 papers

2 papers


